calendar
7,903 catalysts · 5,256 phase readout · 2,323 8k filing · 321 pdufa · 259 earnings · 2 approval · 1 adcom
next 91 dayslessmore
MonWedFri
7,903 catalysts · 5,256 phase readout · 2,323 8k filing · 321 pdufa · 259 earnings · 2 approval · 1 adcom
Items: 5.02
Items: 2.03, 9.01
Items: 5.02, 9.01
Items: 1.01, 3.02, 5.02, 8.01, 9.01
Items: 7.01, 9.01
This page contains notices of advisory committee meetings. Refer to the individual meeting link below for more information on the anticipated format of each meeting. For previous years' advisory committee calendars, see the FDA Archive.
Items: 2.02, 7.01, 9.01
Items: 8.01, 9.01
Items: 1.01, 8.01, 9.01
Items: 8.01, 9.01
Items: 2.02, 8.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 2.02, 9.01
Items: 5.03, 9.01
Items: 2.02, 9.01
Items: 2.02, 9.01
Items: 7.01, 9.01
Items: 3.03, 5.03, 9.01
Items: 5.02, 5.03, 9.01
Items: 2.02, 9.01
Items: 5.08, 8.01, 9.01
Items: 7.01
Items: 2.02, 9.01
Items: 3.01
Items: 8.01, 9.01
Items: 8.01
Items: 1.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 5.02, 7.01, 9.01
Items: 2.02, 9.01
Items: 2.02, 7.01, 9.01
Items: 2.02, 9.01
action date of January 4, 2027
action date of Jan. 21, 2027
Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL
Sponsor: NOVARTIS. Form: TABLET. Route: ORAL
Sponsor: University of Alberta. Phase: . Conditions: Low Back Pain
Sponsor: Beijing Sport University. Phase: NA. Conditions: Patellofemoral Pain
Sponsor: Definium Therapeutics US, Inc.. Phase: PHASE3. Conditions: Major Depressive Disorder